Linezolid-Associated Thrombocytopenia
Author:
- 1 July 2012
- journal article
- case report
- Published by American Society of Consultant Pharmacists in The Consultant Pharmacist
- Vol. 27 (7) , 504-508
Abstract
A 76-year-old man with end-stage renal disease and multiple comorbidities developed progressive thrombocytopenia while receiving linezolid therapy. His platelet count dropped by more than 50% from the baseline after one week of treatment. He subsequently experienced active gastrointestinal bleeding requiring blood transfusion. Drug-induced thrombocytopenia was suspected, and linezolid was discontinued after 10 days of therapy. However, his platelet count continued to decline and reached a nadir of 31 × 103/mm3 on day 13 of his hospital stay. This hematologic adverse effect resolved within nine days after linezolid cessation (day 19). Multiple risk factors for developing linezolid-associated thrombocytopenia were identified in this patient. The accumulation of linezolid and its metabolites because of reduced renal clearance may be contributory to this adverse drug reaction. Clinicians should be vigilant in monitoring platelet counts in elderly patients who are receiving linezolid, especially in those who are at risk for bleeds or who have end-stage renal disease.Keywords
This publication has 15 references indexed in Scilit:
- Clinical Experience with Linezolid at a Large Academic Medical Center: A Case Series and Review of the LiteratureHospital Pharmacy, 2010
- Analysis of Linezolid‐Associated Hematologic Toxicities in a Large Veterans Affairs Medical CenterPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2010
- Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapyClinical Therapeutics, 2009
- Safety of linezolid in patients with baseline thrombocytopeniaJournal of Antimicrobial Chemotherapy, 2008
- Linezolid: low pre-treatment platelet values could increase the risk of thrombocytopeniaJournal of Antimicrobial Chemotherapy, 2005
- Mechanisms for Linezolid-Induced Anemia and ThrombocytopeniaAnnals of Pharmacotherapy, 2003
- Hematologic Effects of Linezolid: Summary of Clinical ExperienceAntimicrobial Agents and Chemotherapy, 2002
- Linezolid‐Induced PancytopeniaClinical Infectious Diseases, 2002
- Linezolid‐Induced Anemia and ThrombocytopeniaPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981